Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan

Study Objectives: Diabetes mellitus per se and its related therapy have been frequently associated with an increased risk of developing dementia. However, studies that explored the risk of dementia from the use of the novel oral antidiabetic medication dipeptidyl peptidase 4 inhibitor (DPP-4i) have...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Med
Main Authors: Chen, Kuan-Chan, Chung, Chi-Hsiang, Lu, Chieh-Hua, Tzeng, Nian-Sheng, Lee, Chien-Hsing, Su, Sheng-Chiang, Kuo, Feng-Chih, Liu, Jhih-Syuan, Hsieh, Chang-Hsun, Chien, Wu-Chien
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141309/
https://ncbi.nlm.nih.gov/pubmed/32121372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9030660
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker